Submit an article

Relapsed/Refractory Hodgkin Lymphoma

Published on April 1, 2025
Exploring the Efficacy and Safety of Pembrolizumab in Relapsed and Refractory Pediatric Hodgkin’s Lymphoma: Insights from the KHCC Experience
Published on April 1, 2025
Pediatric relapsed and refractory classical Hodgkin’s lymphoma: Treatment approaches
Published on April 1, 2025
Immune Checkpoint Inhibitors Treatment in Children with Relapsed/Refractory Hodgkin Lymphoma